AIMS: There are no studies directly comparing self-administration of methamphetamine and d-amphetamine by humans. This study compared intranasal methamphetamine- and d-amphetamine self-administration and characterized the mood, performance and physiological effects produced by the drugs. DESIGN: A randomized, double-blind, placebo-controlled, cross-over study. SETTING: An out-patient research unit at the New York State Psychiatric Institute. PARTICIPANTS: Male recreational methamphetamine users (n = 13). MEASUREMENTS: Five 2-day blocks of sessions were conducted. On the first day of each block, participants 'sampled' a single methamphetamine or d-amphetamine dose (0, 12, 50 mg/70 kg) and a monetary reinforcer ($5 or $20). Amphetamine plasma levels, cardiovascular, mood, and psychomotor performance effects were assessed before drug administration and repeatedly thereafter. On the second day of each block, participants chose between the sampled reinforcers (drug or money). FINDINGS: There were no significant differences between the drugs on the majority of measures. Under the $5 condition, both amphetamines increased self-administration dose-dependently, with 41% drug choices overall. Under the $20 condition, only 17% drug options were selected. Both drugs increased cardiovascular activity and 'positive' mood, although methamphetamine produced more prominent effects on some measures (e.g. heart rate and ratings of 'high'). CONCLUSIONS:Methamphetamine and d-amphetamines appear to produce a similar dose-related profile of effects in humans, which supports their equivalence for abuse potential.
RCT Entities:
AIMS: There are no studies directly comparing self-administration of methamphetamine and d-amphetamine by humans. This study compared intranasal methamphetamine- and d-amphetamine self-administration and characterized the mood, performance and physiological effects produced by the drugs. DESIGN: A randomized, double-blind, placebo-controlled, cross-over study. SETTING: An out-patient research unit at the New York State Psychiatric Institute. PARTICIPANTS: Male recreational methamphetamine users (n = 13). MEASUREMENTS: Five 2-day blocks of sessions were conducted. On the first day of each block, participants 'sampled' a single methamphetamine or d-amphetamine dose (0, 12, 50 mg/70 kg) and a monetary reinforcer ($5 or $20). Amphetamine plasma levels, cardiovascular, mood, and psychomotor performance effects were assessed before drug administration and repeatedly thereafter. On the second day of each block, participants chose between the sampled reinforcers (drug or money). FINDINGS: There were no significant differences between the drugs on the majority of measures. Under the $5 condition, both amphetamines increased self-administration dose-dependently, with 41% drug choices overall. Under the $20 condition, only 17% drug options were selected. Both drugs increased cardiovascular activity and 'positive' mood, although methamphetamine produced more prominent effects on some measures (e.g. heart rate and ratings of 'high'). CONCLUSIONS:Methamphetamine and d-amphetamines appear to produce a similar dose-related profile of effects in humans, which supports their equivalence for abuse potential.
Authors: Sara L Simon; Kimberly Richardson; Jennifer Dacey; Susan Glynn; Catherine P Domier; Richard A Rawson; Walter Ling Journal: J Addict Dis Date: 2002
Authors: Joshua A Lile; Shanna Babalonis; Cleeve Emurian; Catherine A Martin; Daniel P Wermeling; Thomas H Kelly Journal: J Clin Pharmacol Date: 2010-07-29 Impact factor: 3.126
Authors: Carl L Hart; Erik W Gunderson; Audrey Perez; Matthew G Kirkpatrick; Andrew Thurmond; Sandra D Comer; Richard W Foltin Journal: Neuropsychopharmacology Date: 2007-09-12 Impact factor: 7.853
Authors: Matthew G Kirkpatrick; Royce Lee; Margaret C Wardle; Suma Jacob; Harriet de Wit Journal: Neuropsychopharmacology Date: 2014-01-22 Impact factor: 7.853
Authors: Matthew G Kirkpatrick; Tess Boley Cruz; Jennifer B Unger; Josseline Herrera; Sara Schiff; Jon-Patrick Allem Journal: Drug Alcohol Depend Date: 2019-06-08 Impact factor: 4.492
Authors: Diana R Keith; Carl L Hart; Margaret Robotham; Maliha Tariq; Joseph Le Sauter; Rae Silver Journal: Pharmacol Biochem Behav Date: 2013-05-24 Impact factor: 3.533
Authors: D B Vaupel; C W Schindler; S Chefer; A M Belcher; I Ahmet; K B Scheidweiler; M A Huestis; E A Stein Journal: Drug Alcohol Depend Date: 2015-12-24 Impact factor: 4.492